AVEO Pharmaceuticals, Inc. - Common Stock (NQ:AVEO)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 19, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AVEO Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 Next >

Why fuboTV Shares Are Trading Higher By 11%; Here Are 22 Stocks Moving Premarket ↗

October 18, 2022

Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 78.1% to $0.0787 in pre-market trading after gaining 4% on Monday.

Via Benzinga

US Stock Futures Surge Following Monday's Rally; Goldman Sachs, Johnson & Johnson Earnings In Focus ↗

October 18, 2022

Pre-open movers U.S. stock futures traded higher in early pre-market trade on Tuesday after closing sharply higher in the previous session. The Dow Jones jumped by more than 550 points in the previous...

Via Benzinga

LG Chem to Acquire AVEO Oncology for $15.00 Per Share in Cash

October 18, 2022

From AVEO Pharmaceuticals, Inc.

Via GlobeNewswire

AVEO Pharmaceuticals Return On Capital Employed Insights ↗

August 18, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 02, 2022

Via Benzinga

Nasdaq Drops 200 Points; American Woodmark Shares Spike Higher ↗

August 30, 2022

U.S. stocks extended losses toward the end of trading, with the Nasdaq Composite dropping around 200 points on Tuesday

Via Benzinga

Looking Into AVEO Pharmaceuticals's Return On Capital Employed ↗

May 26, 2022

AVEO Pharmaceuticals (NASDAQ:AVEO) brought in sales totaling $20.92 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 40.58%, resulting in a loss of $10.20...

Via Benzinga

Recap: AVEO Pharmaceuticals Q1 Earnings ↗

May 05, 2022

AVEO Pharmaceuticals (NASDAQ:AVEO) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study ↗

May 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Preview: AVEO Pharmaceuticals ↗

May 04, 2022

AVEO Pharmaceuticals (NASDAQ:AVEO) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that AVEO...

Via Benzinga

AVEO Pharmaceuticals Earnings Conference Call Is Coming Up, Here's What You Need To Know ↗

May 04, 2022

AVEO Pharmaceuticals (NASDAQ:AVEO) will host a conference call at 08:30 AM ET on May 5, 2022, to discuss Q1 2022 earnings results.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 18, 2022

Gainers Natus Medical (NASDAQ:NTUS) stock rose 28.3% to $33.42 during Monday's pre-market session. The market value of their outstanding shares is at $1.1 billion....

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

March 17, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

38 Stocks Moving In Tuesday's Mid-Day Session ↗

March 15, 2022

Gainers Incannex Healthcare Limited (NASDAQ: IXHL) shares jumped 131.6% to $53.10 after jumping 54% on Monday. Incannex Healthcare recently completed a preliminary analysis of...

Via Benzinga

68 Biggest Movers From Yesterday ↗

March 16, 2022

Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie...

Via Benzinga

AVEO Pharmaceuticals's Return On Capital Employed Insights ↗

March 15, 2022

According to Benzinga Pro data, during Q4, AVEO Pharmaceuticals (NASDAQ:AVEO) posted sales of $17.65 million. Earnings were up 30.03%, but AVEO Pharmaceuticals still reported an...

Via Benzinga

96 Biggest Movers From Yesterday ↗

March 15, 2022

Gainers Volt Information Sciences, Inc. (NYSE: VOLT) shares surged 94.7% to close at $5.88 on Monday after the company announced it would be acquired for $6 per share. Incannex...

Via Benzinga

50 Stocks Moving In Monday's Mid-Day Session ↗

March 14, 2022

Gainers Volt Information Sciences, Inc. (NYSE: VOLT) shares jumped 95.2% to $5.89 after the company announced it would be acquired for $6 per share. AgriFORCE Growing Systems,...

Via Benzinga

Recap: AVEO Pharmaceuticals Q4 Earnings ↗

March 14, 2022

AVEO Pharmaceuticals (NASDAQ:AVEO) reported its Q4 earnings results on Monday, March 14, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

Earnings Preview For AVEO Pharmaceuticals ↗

March 11, 2022

AVEO Pharmaceuticals (NASDAQ:AVEO) is set to give its latest quarterly earnings report on Monday, 2022-03-14. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Earnings Scheduled For March 14, 2022 ↗

March 14, 2022

Companies Reporting Before The Bell • F45 Training Holdings (NYSE:FXLV) is projected to report earnings for its fourth quarter. • The One Group Hospitality (...

Via Benzinga

Aveo Says Tivozanib Patients Up To 5X More Likely To Experience Long-Term PFS Vs. Nexavar In Kidney Cancer ↗

February 15, 2022

Aveo Pharmaceuticals Inc (NASDAQ: AVEO) will present new long-term progression-free survival (PFS) data from the Phase 3 TIVO-3 study in kidney cancer at the 2022...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 05, 2022

Gainers Lixte Biotech Holdings (NASDAQ:LIXT) stock increased by 70.4% to $2.3 during Wednesday's regular session. Trading volume for this security as of 12:31 EST is...

Via Benzinga

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings ↗

March 13, 2022

Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments...

Via Benzinga

NiKang Therapeutics and AVEO Oncology Announce a Clinical Trial Collaboration and Supply Agreement to Evaluate the Combination of NKT2152, a HIF2α Inhibitor, and FOTIVDA® (tivozanib) for the Treatment of Advanced Clear Cell Renal Cell Carcinoma

January 05, 2022

From NiKang Therapeutics Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 30, 2021

Gainers Kiora Pharmaceuticals (NASDAQ:KPRX) stock moved upwards by 20.4% to $1.06 during Thursday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

AVEO Oncology Announces Appointment of Jeb Ledell as Chief Operating Officer

December 01, 2021

From AVEO Oncology

Via Business Wire

AVEO Oncology Announces Participation at Two Upcoming Virtual Investor Conferences

November 10, 2021

From AVEO Oncology

Via Business Wire

AVEO Oncology Reports Third Quarter 2021 Financial Results and Provides Business Update

November 08, 2021

From AVEO Oncology

Via Business Wire

AVEO Oncology to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 8, 2021

November 01, 2021

From AVEO Oncology

Via Business Wire

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.